KFF March 8, 2023
Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000, has a long record of safety and effectiveness and has been used by more than 5 million people in the United States.
In the most watched case, Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, the court could rule to invalidate the FDAs 23-year-old approval of mifepristone or potentially limit the distribution of this drug for abortion, even in states where abortion remains legal. The ruling could also...
Today's Sponsors
Today's Sponsor